Primary information |
---|
sequence ID | Seq_8962 |
Peptide sequence | VFSNGADLSGVTEEAPLKLS |
CancerPDF_ID | CancerPDF_ID744, CancerPDF_ID1623, CancerPDF_ID2835, |
PMID | 19795908,21136997,21136997 |
Protein Name | Alpha-1-antitrypsin,Alpha-1 protease inhibitor,Alpha-1 protease inhibitor |
UniprotKB Entry Name | A1AT_HUMAN,NA,NA |
Fluid | Plasma,Serum,Plasma |
M/Z | 1017.52,2033.0317,2033.0317 |
Charge | 2,1,1 |
Mass (in Da) | NA,NA,NA |
fdr | NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS |
Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS |
Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS |
Labelled/Label Free | Labelled,Label Free,Label Free |
FDR | less than 7%,NA,NA |
CancerPDF_ID | CancerPDF_ID744, CancerPDF_ID1623, CancerPDF_ID2835, |
p-Value | NA,NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01) |
Length | 20,20,20 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal |
Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "40 normal, 26 patients",30 patients and 30 healthy controls,27 healthy individuals |
Regulation | NA,NA,NA |
Validation | NA,Leave One out Cross validation,Leave One out Cross validation |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |